Jennifer Gorzelany

Jennifer Gorzelany serves as the Head of Strategy at Laurelwood, a consulting firm specializing in life sciences, which she founded to provide strategic guidance in the field. She has played pivotal roles in the launch of biotech companies such as Voyager Therapeutics and Lotus Tissue Repair. Additionally, Jennifer has provided advisory support to several precision medicine companies, including Rhythm Pharmaceuticals and Fulcrum Therapeutics. Her extensive experience also includes holding various business and intellectual property positions at Dyax Corp, where she eventually became the Director of Competitive Intelligence. Jennifer holds a B.A. in Biology from Boston University and is a licensed Patent Agent through the U.S. Patent and Trademark Office, underscoring her expertise in both the scientific and patent domains.